OPTIMIND PHARMA CORP.

News Optimind Pharma Corp.

Equities

OMND

CA68405U1012

Market Closed - Canadian Securities Exchange Other stock markets 07:00:00 14/05/2024 pm IST			5-day change	1st Jan Change
0.005 ^CAD	0.00%		0.00%	0.00%

26/01	Optimind Pharma Reaches Agreement On Debenture Conversion	MT
10/01	Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Optimind Pharma Reaches Agreement On Debenture Conversion	27/01	MT
Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023	11/01	CI
Optimind Pharma Corp. Announces Executive Changes	08/01	CI
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023	31/23/31	CI
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions	13/23/13	GL
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended May 31, 2023	28/23/28	CI
Optimind Pharma Corp. Auditor Raises 'Going Concern' Doubt	28/23/28	CI
Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	28/23/28	CI
Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy	21/22/21	AQ
Optimind Pharma Corp. acquired MindSetting Inc. from Beatrice Society Inc. for CAD 1.6 million.	20/22/20	CI
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26/22/26	CI
Optimind Pharma Corp. Provides Update on Health Canada's Dealer License Under Joint-Venture with Manitari Pharma Corporation	10/22/10	CI
Reverse Split: 1 of 1.713084	04/22/04	FA
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	03/22/03	CI
Optimind Pharma Inc. completed the acquisition of Loon Energy Corporation (TSXV:LNE.H) in a reverse merger transaction.	28/22/28	CI
Optimind Pharma Corp. announced that it has received CAD 0.507 million in funding	04/22/04	CI
Optimind Pharma Inc. entered into a letter of intent to acquire Loon Energy Corporation (TSXV:LNE.H) for CAD 8.3 million in a reverse merger transaction.	16/21/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
OMND Stock
News Optimind Pharma Corp.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW